THE DEFINITIVE GUIDE TO MBL77

mutations supplied the fact that, as described down below, CLL therapy is based about the existence or absence of such mutations. The current consensus is always that, in addition to clonal mutations, subclonal mutations using a variant allelic frequency ranging from five to ten% (and therefore beneath the brink of detection by traditional molecula